Fig. 1From: The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7The clinical detection value of miR-26 in HCC. IFN-α therapy was more effective in HCC patients with low miR-26 expression. HCC, hepatocellular carcinoma; IFN-α, interferon-α; MIR26-DX, standardized diagnostic tests for miR-26; RCC, renal cell cancerBack to article page